new_0222_0352|LYEL|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0352|LYEL|Long Name|1|1|Lyell Immunopharma Inc Total Current Assets (Quarterly) (USD)|Lyell Immunopharma Inc Cash and Short Term Investments (Quarterly) (USD)|Lyell Immunopharma Inc Inventories (Quarterly) (USD)|Lyell Immunopharma Inc Net PP&E (Quarterly) (USD)|Lyell Immunopharma Inc Goodwill and Intangibles (Quarterly) (USD)|Lyell Immunopharma Inc Total Liabilities (Quarterly) (USD)|Lyell Immunopharma Inc Total Current Liabilities (Quarterly) (USD)|Lyell Immunopharma Inc Total Long Term Liabilities (Quarterly) (USD)|Lyell Immunopharma Inc Total Deposits (Quarterly) (USD)|Lyell Immunopharma Inc Book Value (Quarterly) (USD)|Lyell Immunopharma Inc Retained Earnings (Quarterly) (USD)|Lyell Immunopharma Inc Treasury Stock (Quarterly) (USD)|Lyell Immunopharma Inc EV to Revenues|Lyell Immunopharma Inc EV to Earnings|Lyell Immunopharma Inc EV to Free Cash Flow|Lyell Immunopharma Inc EV to Assets (Quarterly)|Lyell Immunopharma Inc PS Ratio|Lyell Immunopharma Inc PE Ratio|Lyell Immunopharma Inc Price to Book Value|Lyell Immunopharma Inc PEG Ratio|Lyell Immunopharma Inc Debt to Equity Ratio|Lyell Immunopharma Inc Dividend Yield|Lyell Immunopharma Inc Shareholder Yield (TTM)|Lyell Immunopharma Inc Percent of Shares Outstanding Short|Lyell Immunopharma Inc Total Receivables (Quarterly) (USD)|Lyell Immunopharma Inc Total Payables (Quarterly) (USD)|Lyell Immunopharma Inc Total Capital Stock (Quarterly) (USD)|Lyell Immunopharma Inc Return on Invested Capital|Lyell Immunopharma Inc Quality Ratio Score|Lyell Immunopharma Inc Momentum Score|Lyell Immunopharma Inc Beta (1Y)|Lyell Immunopharma Inc Sustainable Growth Rate (TTM)|Lyell Immunopharma Inc Institutional Investor Ownership Percentage|Lyell Immunopharma Inc Average Diluted Shares Outstanding (Quarterly)|Lyell Immunopharma Inc Total Employees (Annual)|Lyell Immunopharma Inc EPS Diluted (Quarterly) (USD)|Lyell Immunopharma Inc SG&A Expense (Quarterly) (USD)|Lyell Immunopharma Inc Shares Outstanding|Lyell Immunopharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Lyell Immunopharma Inc Ordinary Shares Number (Quarterly)|Lyell Immunopharma Inc Payout Ratio|Lyell Immunopharma Inc Quick Ratio (Quarterly)|Lyell Immunopharma Inc Normalized Diluted EPS (Quarterly) (USD)|Lyell Immunopharma Inc Stock Buybacks (Quarterly) (USD)|Lyell Immunopharma Inc Effective Tax Rate (TTM)|Lyell Immunopharma Inc Return on Equity|Lyell Immunopharma Inc Net Income (TTM) (USD)|Lyell Immunopharma Inc Revenue (TTM) (USD)|Lyell Immunopharma Inc Dividend Per Share (Quarterly) (USD)|Lyell Immunopharma Inc Revenue (Quarterly) (USD)|Lyell Immunopharma Inc Gross Profit (Quarterly) (USD)|Lyell Immunopharma Inc Pre-Tax Income (Quarterly) (USD)|Lyell Immunopharma Inc Net Income (Quarterly) (USD)|Lyell Immunopharma Inc Net Interest Income (Quarterly) (USD)|Lyell Immunopharma Inc Price (USD)|Lyell Immunopharma Inc Total Return Price (USD)|Lyell Immunopharma Inc Enterprise Value (USD)|Lyell Immunopharma Inc 30-Day Average Daily Volume|Lyell Immunopharma Inc 1 Year Price Returns (Daily)|Lyell Immunopharma Inc Short Interest|Lyell Immunopharma Inc PE Ratio (Forward)|Lyell Immunopharma Inc PE Ratio (Forward 1y)|Lyell Immunopharma Inc PS Ratio (Forward)|Lyell Immunopharma Inc PS Ratio (Forward 1y)|Lyell Immunopharma Inc Quarterly EPS Estimates (USD)|Lyell Immunopharma Inc Quarterly Revenue Estimates (USD)|Lyell Immunopharma Inc Quarterly EPS Surprise|Lyell Immunopharma Inc Quarterly Revenue Surprise|Lyell Immunopharma Inc Quarterly Actual EPS (USD)|Lyell Immunopharma Inc Quarterly Actual Revenue (USD)|Lyell Immunopharma Inc Revenue Estimates for Current Fiscal Year (USD)|Lyell Immunopharma Inc Revenue Estimates for Next Fiscal Year (USD)|Lyell Immunopharma Inc Price Target (USD)|Lyell Immunopharma Inc Consensus Recommendation|Lyell Immunopharma Inc Price Target Num Estimates|Lyell Immunopharma Inc EPS Estimates for Current Fiscal Year (USD)|Lyell Immunopharma Inc EPS Estimates for Next Fiscal Year (USD)|Lyell Immunopharma Inc Research and Development Expense (Quarterly) (USD)|Lyell Immunopharma Inc Reconciled Depreciation (Quarterly) (USD)|Lyell Immunopharma Inc Non-Operating Interest Expense (Quarterly) (USD)|Lyell Immunopharma Inc Land and Improvements (Quarterly) (USD)|Lyell Immunopharma Inc Buildings and Improvements (Quarterly) (USD)|Lyell Immunopharma Inc Other Properties (Quarterly) (USD)|Lyell Immunopharma Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0352|LYEL|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0352|LYEL||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0352|LYEL||5|5|91|91|0|91|0|91|91|91|0|91|91|0|1.43859649123|92|1.43859649123|92|1.43859649123|0|1.43827160494|0|91|1.43859649123|92|15.3571428571|0|91|91|92|0|0|0|92|30.7142857143|91.3333333333|0|91.3333333333|91.3333333333|29.8|91.3333333333|91|91|91|91.3333333333|91.3333333333|0|92|91|91|0|91.3333333333|0|91.3333333333|91.3333333333|91.3333333333|1.43859649123|1.43859649123|1.43859649123|1.43661971831|0|15.3571428571|0|0|1.44117647059|1.44117647059|91.25|91.4|92|92|92|92|22.5555555556|25.375|40.6|18.4545454545|40.6|20.3|29|91.3333333333|91.3333333333|0|0|0|91|0
new_0222_0352|LYEL||6|6|3|3|0|3|0|3|3|3|0|3|3|0|171|1|171|1|171|0|162|0|3|171|1|14|0|3|3|1|0|0|0|1|7|6|0|6|6|5|6|3|3|3|6|6|0|1|3|3|0|6|0|6|6|6|171|171|171|142|0|14|0|0|34|34|4|5|1|1|1|1|9|8|5|11|5|10|7|6|6|0|0|0|3|0
new_0222_0352|LYEL||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0352|LYEL|202003|202003|202003||||||||||||||||||||||||||||||||||211.746||-0.155|8.88||-16.05||||-0.155|11.806||||||1.256||-29.24|-29.24|2.341||||||||||||||||||||||||25.5|0.776|||||
new_0222_0352|LYEL|202006|202006|202006||||||||||||||||||||||||||||||||||211.746||-0.4754|9.562||0||||-0.4754|0||||||3.118||-100.656|-100.656|1.881||||||||||||||||||||||||97.152|0.962|||||
new_0222_0352|LYEL|202009|202009|202009||||||||||||||||||||||||||||||||||211.746||-0.1687|13.57||0||||-0.1687|0||||||1.07||-35.719|-35.719|1.096||||||||||||||||||||||||24.501|1.104|||||
new_0222_0352|LYEL|202012|202012|202012|617.547|612.619||124.055||189.84|49.285|140.555||-292.528|-334.143||||||||||0|||||9.396|1010.97|||||||211.746||-0.1835|14.869||0|242.83|0|12.4301|-0.1835|0|||-204.472|7.756||2.312||-38.857|-38.857|0.621||||||||||||||||||||||||35.09|1.452||||64.093|0.902
new_0222_0352|LYEL|202103|202103|202103|609.735|604.933||144.874||200.269|56.812|143.457||-334.048|-389.186||||||||||0|||||7.121|1010.97|||||||211.746|190|-0.26|16.831||0|242.83|0|10.648|-0.26|0|||-230.275|8.945||2.445||-55.043|-55.043|0.354||||||||||||||||||||||||41.529|1.958||||144.874|
new_0222_0352|LYEL|202106|202106|202106|834.84|824.523||158.061||207.912|63.663|144.249||1021.955|-451.781||360.6757|-15.8652|-15.4748|2.4795|325.5448||3.7908||0|0|-10.1409|0.5527||4.863|0.024|-23.8546||||-145.8454|33.5543|42.713||-1.47|19.112|238.549|0|238.549|0|12.9514|-1.47|-392.862||-145.8454|-192.214|8.455||2.628||-62.595|-62.595|0.218|16.24|16.24|3049.5128|||1318441|||||-0.8702|2.25|-2.4453|16.8|-0.8915|2.628||||||||46.446|3.01||||158.061|
new_0222_0352|LYEL|202107|202106|202106|||||||||||||311.5834||-13.3685||290.665||3.3846|||0||1.1524|||||||||33.8163||||||||||||||||||||||14.5|14.5|2634.4375|475060.0333||2749099|||||||||||9.232|27.6916|25.5|1.75|4|-1.3545|-1.1374|||||||
new_0222_0352|LYEL|202108|202106|202106|||||||||||||349.5653||-14.9981||316.5241||3.6989|||0||1.4016|||||||||33.7155|||||239.3982|||||||||||||||||15.79|15.79|2955.5746|206092.0333||3355392|||||||||||10.0227|37.6594|25.5|1.75|4|-1.407|-1.1636|||||||
new_0222_0352|LYEL|202109|202109|202109|631.147|618.921||163.093||211.86|59.281|152.579||986.474|-500.656||288.9503|-14.2667|-14.6553|2.445|257.4634||3.5975||0|0|-11.0402|1.7817||3.526|0.024|-24.1343||||-59.4477|34.2608|239.384||-0.2|21.241|239.789|0|239.789|0|10.4405|-0.2|1.06||-59.4477|-205.37|10.14||2.755||-48.875|-48.875|0.27|14.8|14.8|2929.9562|677984.2333||4272231|||||-0.5183|2.3|71.25|19.7826|-0.149|2.755||||||||31.433|4.091||||163.093|
new_0222_0352|LYEL|202110|202109|202109|||||||||||||268.6132||-13.6238||242.5027||3.3885|||0||2.0626|||||||||34.5069||||||||||||||||||||||13.94|13.94|2723.7377|319652.7333||4945847||||||||||||||||||||||||
new_0222_0352|LYEL|202111|202109|202109|||||||||||||165.442||-8.3911||166.1335||2.328|||0||2.2025|||||||||34.554|||||240.4715|||||||||||||||||9.55|9.55|1677.5818|265988.3667||5296483|||||||||||10.4993|38.1441|25.75|1.75|4|-1.988|-1.185|||||||
new_0222_0352|LYEL|202112|202112|202112|||||||||||||122.5176||-6.214||134.6464||1.8868|||0||3.1644|||||||||34.6742||||||||||||||||||||||7.74|7.74|1242.3284|765122.9333||7609366|||66.4382|59.3282|-0.24|2.85|||||9.6887|28.0147||1.75||-1.5093||||||||
new_0222_0352|LYEL|202201|202112|202112|||||||||||||73.6644||-3.7362||98.8103||1.3846|||0||3.5818|||||||||34.5492||||||||||||||||||||||5.68|5.68|746.9571|885056.4667||8613315|||48.7557|43.538|||||||28.0147|31.3721|22|1.75|4|-1.185|-1.01|||||||
new_0222_0352|LYEL|202202|202112|202112|||||||||||||81.0161||-4.1091||104.2031||1.4602|||0|||||||||||||||||||||||||||||||||5.99|5.99|821.5033|708699.3667|||||51.4166|45.9142||||||||||||||||||||
new_0222_0352|LYEL|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.3|3||||||||||||||||||
new_0222_0352|LYEL|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.31|3.2||||||||||||||||||
new_0222_0352|LYEL|202209|202209|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||3.4||||||||||||||||||